Two new tanshinone derivatives from the rhizomes of Salvia miltiorrhiza and their antiviral activities-Reference-Cited by-同舟云学术

Two new tanshinone derivatives from the rhizomes of Salvia miltiorrhiza and their antiviral activities

Published:2019-08-01 Issue:1 Volume:22 Page:24-29
ISSN:1028-6020
Container-title:Journal of Asian Natural Products Research
language:en
Short-container-title:Journal of Asian Natural Products Research

Author:

Yin Zhao-Kun¹,Feng Zi-Ming¹,Jiang Jian-Shuang¹,Zhang Xu¹,Zhang Pei-Cheng¹,Yang Ya-Nan¹

Affiliation:

1. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Peking Union Medical College and Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China

Publisher

Informa UK Limited

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine,Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10286020.2019.1645132

Reference9 articles.

1. Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology

2. Constituents from Salvia Species and Their Biological Activities

3. Cancer Chemopreventive Activities of S-3-1, A Synthetic Derivative of Danshinone

4. New abietane norditerpenoid from Salvia miltiorrhiza with cytotoxic activities

5. Oxazole-Containing Diterpenoids from Cell Cultures of Salvia miltiorrhiza and Their Anti-HIV-1 Activities

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms;Acta Pharmaceutica Sinica B;2023-05

2. Antiviral properties of diterpenes and their derivatives;Успехи химии;2023-01

3. Anti-Influenza Activity of Extracts from Plants of the Lamiaceae Family;Russian Journal of Bioorganic Chemistry;2022-12

4. Herbal Medicines as Potential Inhibitors of SARS-CoV-2 Infection;Current Pharmaceutical Design;2022-08

5. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19;Current Pharmaceutical Design;2021-10-12